HOB Biotech Shares Owned By Institutions vs. Market Capitalization

688656 Stock   101.27  0.96  0.94%   
Considering the key profitability indicators obtained from HOB Biotech's historical financial statements, HOB Biotech Group may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess HOB Biotech's ability to earn profits and add value for shareholders.
For HOB Biotech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of HOB Biotech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well HOB Biotech Group utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between HOB Biotech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of HOB Biotech Group over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between HOB Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if HOB Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HOB Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

HOB Biotech Group Market Capitalization vs. Shares Owned By Institutions Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining HOB Biotech's current stock value. Our valuation model uses many indicators to compare HOB Biotech value to that of its competitors to determine the firm's financial worth.
HOB Biotech Group is number one stock in shares owned by institutions category among its peers. It also is number one stock in market capitalization category among its peers creating about  2,059,972,212  of Market Capitalization per Shares Owned By Institutions. Comparative valuation analysis is a catch-all model that can be used if you cannot value HOB Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for HOB Biotech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

HOB Market Capitalization vs. Shares Owned By Institutions

Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

HOB Biotech

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

 = 
3.10 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

HOB Biotech

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
6.39 B
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

HOB Market Capitalization vs Competition

HOB Biotech Group is number one stock in market capitalization category among its peers. Market capitalization of Health Care industry is presently estimated at about 14.77 Trillion. HOB Biotech adds roughly 6.39 Billion in market capitalization claiming only tiny portion of equities under Health Care industry.
Capitalization  Valuation  Workforce  Total debt  Revenue

HOB Biotech Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in HOB Biotech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, HOB Biotech will eventually generate negative long term returns. The profitability progress is the general direction of HOB Biotech's change in net profit over the period of time. It can combine multiple indicators of HOB Biotech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income55.2 M59.4 M
Income Before Tax56.6 M57.3 M
Total Other Income Expense Net-1.3 M-1.3 M
Net Income47.9 M49.8 M
Income Tax Expense5.6 M7.2 M
Net Interest Income-1.2 M-1.2 M
Interest Income1.6 MM
Net Income From Continuing Ops47.3 M47.3 M

HOB Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on HOB Biotech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of HOB Biotech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the HOB Biotech's important profitability drivers and their relationship over time.

Use HOB Biotech in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if HOB Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HOB Biotech will appreciate offsetting losses from the drop in the long position's value.

HOB Biotech Pair Trading

HOB Biotech Group Pair Trading Analysis

The ability to find closely correlated positions to HOB Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace HOB Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back HOB Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling HOB Biotech Group to buy it.
The correlation of HOB Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as HOB Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if HOB Biotech Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for HOB Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your HOB Biotech position

In addition to having HOB Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Sport Products Thematic Idea Now

Sport Products
Sport Products Theme
Companies manufacturing sporting goods and accessories. The Sport Products theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sport Products Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in HOB Stock

To fully project HOB Biotech's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of HOB Biotech Group at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include HOB Biotech's income statement, its balance sheet, and the statement of cash flows.
Potential HOB Biotech investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although HOB Biotech investors may work on each financial statement separately, they are all related. The changes in HOB Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on HOB Biotech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.